State UT
Clinical Trials in Utah
Recruiting clinical trials with at least one study location in Utah. Data updated daily from ClinicalTrials.gov.
Top Conditions in Utah
NCT06124118 Phase 1
Recruiting
Tumor Treating Fields for Locally Advanced NSCLC
Condition
Non Small Cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
University of Utah
NCT06193889 Phase 2, Phase 3
Recruiting
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patien...
Condition
Myasthenia Gravis
Enrollment
66 pts
Location
United States, Brazil, Germany
Sponsor
Kyverna Therapeutics
NCT05913908 N/A
Recruiting
EFS of the DUO System for Tricuspid Regurgitation
Condition
Tricuspid Regurgitation
Enrollment
15 pts
Location
United States, Poland
Sponsor
CroiValve Limited
NCT04665739 Phase 2
Recruiting
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive...
Condition
Advanced Lung Neuroendocrine Tumor
Enrollment
70 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07298330 Phase 3
Recruiting
A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic ...
Condition
Chronic Hepatitis D Infection
Enrollment
80 pts
Location
United States, Belgium, Bulgaria
Sponsor
Mirum Pharmaceuticals, Inc.
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT06655896 Phase 2
Recruiting
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cu...
Condition
Scleroderma, Diffuse
Enrollment
96 pts
Location
United States, Australia, Austria
Sponsor
Novartis Pharmaceuticals
NCT03511118 N/A
Recruiting
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breast...
Condition
Lactating Women on Select DOI
Enrollment
1,600 pts
Location
United States, Canada
Sponsor
Duke University
NCT05875168 Phase 1, Phase 2
Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
540 pts
Location
United States, Belgium, Canada
Sponsor
Daiichi Sankyo
NCT06872125 Phase 3
Recruiting
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevu...
Condition
Dravet Syndrome
Enrollment
170 pts
Location
United States, Japan, United Kingdom
Sponsor
Stoke Therapeutics, Inc
NCT05836987 Phase 3
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial F...
Condition
Atrial Fibrillation
Enrollment
5,350 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06805513 Phase 3
Recruiting
Actual Use Trial of Tadalafil 5 mg
Condition
Erectile Dysfunction
Enrollment
2,250 pts
Location
United States
Sponsor
Sanofi
NCT07093580 Phase 1
Recruiting
Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Condition
Healthy Participants
Enrollment
98 pts
Location
United States
Sponsor
Shionogi
NCT04239703 N/A
Recruiting
Trifecta-Kidney cfDNA-MMDx Study
Condition
Kidney Transplant Rejection
Enrollment
300 pts
Location
United States, Australia, Canada
Sponsor
University of Alberta
NCT05033990 N/A
Recruiting
SPIROMICS Study of Early COPD Progression (SOURCE)
Condition
COPD, Early-Onset
Enrollment
1,000 pts
Location
United States
Sponsor
University of Massachusetts, W
NCT06132503 Phase 1
Recruiting
Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With...
Condition
Relapsed or Refractory Lymphomas
Enrollment
110 pts
Location
United States
Sponsor
Lantern Pharma Inc.
NCT05143840 Phase 2
Recruiting
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chron...
Condition
Chronic Myeloid Leukemia, Chronic Phase
Enrollment
100 pts
Location
United States
Sponsor
Augusta University
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT05929703 N/A
Recruiting
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized ...
Condition
Delirium
Enrollment
1,900 pts
Location
United States
Sponsor
University of Michigan
NCT06541262 Phase 1, Phase 2
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory...
Condition
Neuroblastoma
Enrollment
104 pts
Location
United States, Canada
Sponsor
Milton S. Hershey Medical Cent
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT05329103 Phase 1
Recruiting
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
65 pts
Location
United States
Sponsor
Peel Therapeutics Inc
NCT07215312 Phase 2
Recruiting
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated Wit...
Condition
Diabetes Mellitus, Type 2
Enrollment
100 pts
Location
United States, Argentina
Sponsor
Eli Lilly and Company
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Me...
Condition
Urothelial Cancer
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT05661461 Phase 1
Recruiting
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in ...
Condition
Tumor, Solid
Enrollment
28 pts
Location
United States
Sponsor
Aadi Bioscience, Inc.